CONTEXT: Glycated hemoglobin (A1C) has been recommended by the American Diabetes Association for the diagnosis of diabetes and prediabetes. The diagnostic utility of A1C has not been evaluated in Arabs, a population at increased risk for developing diabetes. OBJECTIVE: Our objective was to examine the sensitivity and specificity of A1C for the diagnosis of diabetes and prediabetes in Arabs. DESIGN & SETTING: In this cross-sectional study, glucose tolerance was classified by the American Diabetes Association diagnostic criteria specified for A1C, fasting plasma glucose, and 75-g oral glucose tolerance test. PARTICIPANTS: A population-based representative sample of 482 randomly selected adult Arabs without known diabetes was studied. MAIN OUTCOME MEASURES: Sensitivity, specificity, and area under the receiver operating characteristic curve of A1C diagnostic cutpoints for diabetes and prediabetes were calculated. κ Coefficients were used to test for agreement between A1C categorization and glucose-based diagnoses. RESULTS: A1C testing correctly identified 5% of individuals diagnosed with diabetes by oral glucose tolerance test, 13% by fasting plasma glucose, and 41% by both criteria. A1C alone identified 14% of individuals diagnosed with impaired glucose tolerance, 9% with impaired fasting glucose, and 33% with both abnormalities. Sensitivity, specificity, and area under the receiver operating characteristic curve were 19% (16-23%), 100% (99-100%), and 77% (69-85%) for diabetes A1C cutpoint and 14% (11-17%), 91% (89-94%), and 57% (52-62%) for prediabetes A1C range. A1C cutpoint of 6.2% for diabetes and 5.1% for prediabetes yielded the highest accuracy but still missed 73% of those with diabetes and 31% with prediabetes. Agreement between A1C and diabetes (κ = 0.2835) or prediabetes (κ = 0.0530) was low. CONCLUSIONS: A1C-based criteria yield a high proportion of false-negative tests for diabetes and prediabetes in Arabs. SUMMARY: Racial/ethnic differences in A1C performance for diagnosis and prediction of diabetes exist. This paper examines its utility against glucose measurements in an at-risk Arab population.
CONTEXT: Glycated hemoglobin (A1C) has been recommended by the American Diabetes Association for the diagnosis of diabetes and prediabetes. The diagnostic utility of A1C has not been evaluated in Arabs, a population at increased risk for developing diabetes. OBJECTIVE: Our objective was to examine the sensitivity and specificity of A1C for the diagnosis of diabetes and prediabetes in Arabs. DESIGN & SETTING: In this cross-sectional study, glucose tolerance was classified by the American Diabetes Association diagnostic criteria specified for A1C, fasting plasma glucose, and 75-g oral glucose tolerance test. PARTICIPANTS: A population-based representative sample of 482 randomly selected adult Arabs without known diabetes was studied. MAIN OUTCOME MEASURES: Sensitivity, specificity, and area under the receiver operating characteristic curve of A1C diagnostic cutpoints for diabetes and prediabetes were calculated. κ Coefficients were used to test for agreement between A1C categorization and glucose-based diagnoses. RESULTS:A1C testing correctly identified 5% of individuals diagnosed with diabetes by oral glucose tolerance test, 13% by fasting plasma glucose, and 41% by both criteria. A1C alone identified 14% of individuals diagnosed with impaired glucose tolerance, 9% with impaired fasting glucose, and 33% with both abnormalities. Sensitivity, specificity, and area under the receiver operating characteristic curve were 19% (16-23%), 100% (99-100%), and 77% (69-85%) for diabetesA1C cutpoint and 14% (11-17%), 91% (89-94%), and 57% (52-62%) for prediabetesA1C range. A1C cutpoint of 6.2% for diabetes and 5.1% for prediabetes yielded the highest accuracy but still missed 73% of those with diabetes and 31% with prediabetes. Agreement between A1C and diabetes (κ = 0.2835) or prediabetes (κ = 0.0530) was low. CONCLUSIONS:A1C-based criteria yield a high proportion of false-negative tests for diabetes and prediabetes in Arabs. SUMMARY: Racial/ethnic differences in A1C performance for diagnosis and prediction of diabetes exist. This paper examines its utility against glucose measurements in an at-risk Arab population.
Authors: Christine L Chan; Laura Pyle; Lindsey Newnes; Kristen J Nadeau; Philip S Zeitler; Megan M Kelsey Journal: J Clin Endocrinol Metab Date: 2014-12-22 Impact factor: 5.958
Authors: Arsene F Hobabagabo; Nana H Osei-Tutu; Thomas Hormenu; Elyssa M Shoup; Christopher W DuBose; Lilian S Mabundo; Joon Ha; Arthur Sherman; Stephanie T Chung; David B Sacks; Anne E Sumner Journal: Diabetes Care Date: 2020-08-14 Impact factor: 19.112
Authors: Maria A Marini; Elena Succurro; Ersilia Castaldo; Sabrina Cufone; Franco Arturi; Angela Sciacqua; Renato Lauro; Marta L Hribal; Francesco Perticone; Giorgio Sesti Journal: Diabetes Care Date: 2012-03-07 Impact factor: 19.112
Authors: Kasia J Lipska; Silvio E Inzucchi; Peter H Van Ness; Thomas M Gill; Alka Kanaya; Elsa S Strotmeyer; Annemarie Koster; Karen C Johnson; Bret H Goodpaster; Tamara Harris; Nathalie De Rekeneire Journal: Diabetes Care Date: 2013-10-17 Impact factor: 19.112